Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial (vol 22, pg 1704, 2024)

被引：0

作者：

McBane Ii, Robert D. ^{[1
]}

Loprinzi, Charles L. ^{[2
]}

Zemla, Tyler ^{[3
]}

Tafur, Alfonso ^{[4
]}

Sanfilippo, Kristen ^{[5
]}

Liu, Jane Jijun ^{[6
]}

Garcia, David A. ^{[7
]}

Heun, James ^{[8
]}

Gundabolu, Krishna ^{[9
]}

Onitilo, Adedayo A. ^{[10
]}

Perepu, Usha ^{[11
]}

Drescher, Monic R. ^{[12
]}

Henkin, Stanislav ^{[12
]}

Houghton, Damon ^{[1
]}

Ashrani, Aneel ^{[13
]}

Billett, Henny ^{[14
]}

Mooberry, Micah J. ^{[15
]}

Mccue, Shaylene A.

Lee, Minji K. ^{[3
]}

Le-Rademacher, Jennifer G. ^{[3
]}

Wysokinski, Waldemar E. ^{[1
]}

机构：

[1] Mayo Clin, Gonda Vasc Ctr, Vasc Med Div, Rochester, MN 55905 USA

[2] Mayo Clin, Dept Med Oncol, Rochester, MN USA

[3] Mayo Clin, Clin trials & Biostat, Rochester, MN USA

[4] North Shore Univ Hlth Syst, Cardiovasc Div, Evanston, IL USA

[5] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO USA

[6] Illinois Canc Care, Hematol & Med Oncol, Peoria, IL USA

[7] Univ Washington, Hematol Div, Seattle, WA USA

[8] Dean Hematol & Med Oncol Grp, Madison, WI USA

[9] Univ Nebraska Med Ctr, Hematol & Med Oncol, Omaha, NE USA

[10] Marshfield Clin Fdn Med Res & Educ, Canc Care & Res Ctr, Marshfield, WI USA

[11] Univ Iowa, Holden Comprehens Canc Ctr, Hematol & Med Oncol, Iowa City, IA USA

[12] Dartmouth Hitchcock Med Ctr, Cardiovasc Med, Lebanon, NH USA

[13] Mayo Clin, Hematol Div, Rochester, MN USA

[14] Montefiore Med Ctr, Bronx, NY USA

[15] Univ North Carolina, Chapel Hill, NC USA

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2025年 / 23卷 / 02期

关键词：

D O I：

10.1016/j.jtha.2024.12.011

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：756 / 756

页数：1

共 50 条

[21] Predictors of recurrent venous thromboembolism and major bleeding in patients with cancer: A secondary analysis of the CANVAS trial
Uno, Hajime
Xiong, Hong
Cronin, Christine
Schrag, Deborah
Connors, Jean M.
THROMBOSIS RESEARCH, 2024, 244
[22] Comparison of tinzaparin and acenocoumarol for the secondary prevention of venous thromboembolism: a multicentre, randomized study (vol 21, pg 744, 2010)
Perez-de-Llano, Luis A.
BLOOD COAGULATION & FIBRINOLYSIS, 2011, 22 (01) : 79 - 79
[23] "Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients-30 months follow-up": Reply
Larsen, Trine-Lise
Garresori, Herish
Brekke, Jorunn
Enden, Tone
Froen, Hege
Jacobsen, Eva Marie
Quist-Paulsen, Petter
Porojnicu, Alina Carmen
Ree, Anne Hansen
Torfoss, Dag
Velle, Elin Osvik
Wik, Hilde Skuterud
Ghanima, Waleed
Sandset, Per Morten
Dahm, Anders Erik Astrup
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022, 20 (08) : 1937 - 1939
[24] Prognostic relevance of an asymptomatic venous thromboembolism in patients with cancer (vol 9, pg 1081, 2011)
Dentali, F.
Ageno, W.
Pierfranceschi, Giorgi M.
Imberti, D.
Malato, A.
Nitti, C.
Salvi, A.
Siragusa, S.
Squizzato, A.
Vitale, J.
Agnelli, G.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (01) : 224 - 224
[25] American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer (vol 5, pg 927, 2021)
Lyman, G. H.
Carrier, M.
Ay, C.
BLOOD ADVANCES, 2021, 5 (07) : 1953 - 1953
[26] Is low-molecular-weight heparin safer than warfarin for secondary prevention of venous thromboembolism in cancer patients?
Caine, G
Lip, GYH
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (10) : 1243 - 1244
[27] Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer: a randomized clinical trial (vol 314, pg 677, 2015)
Lee, A. Y.
Kamphuisen, P. W.
Meyer, G.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (20): : 2048 - 2048
[28] DIVERSITY Study Investigators. Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children (vol 135, pg 491, 2020)
Brandao, L. R.
Albisetti, M.
Halton, J.
BLOOD, 2020, 135 (19) : 1720 - 1720
[29] A nomogram to predict the risk of venous thromboembolism in patients with colon cancer in China (vol 13, e7231, 2024)
Yang, Y.
Zhan, J.
Li, X.
Hua, J.
Lei, H.
Chen, X.
CANCER MEDICINE, 2024, 13 (10):
[30] Primary prevention of venous thromboembolism for cancer patients in randomized controlled trials: a bibliographical analysis of funding and trial characteristics
Zhao, Lucy
Kherani, Jayhan
Li, Pei Ye
Zhang, Kevin
Horta, Angelina
Lin, Christine
Li, Allen
Eshaghpour, Ali
Crowther, Mark Andrew
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2024, 8 (01)

← 1 2 3 4 5 →